Liquid biopsy company Karius Inc. said today that it has received $100m in series C funding co-led by Khosla Ventures and news investors 5AM Ventures and Gilde Healthcare. Additional investors include Seventure Partners as well as existing investors Softbank Vision Fund 2, General Catalyst, HBM Healthcare Investments, Blue Water Life Sciences, Innovation Endeavors, Waycross Ventures and others.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?